节点文献

帕利哌酮缓释片临床用药指导意见

Clinical recommendation on paliperidone extended-release tablet in schizophrenia therapy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 舒良蔡焯基吉中孚江开达司天梅张鸿燕梅其一贾福军陆峥许秀峰孙静邓红关念红李晓白焦志安张克让

【Author】 SHU Liang1,CAI Zhuo-ji2,JI Zhong-fu3,JIANG Kai-da4,SI Tian-mei1,ZHANG Hong-yan1, MEI Qi-yi5,JIA Fu-jun6,LU Zheng7,XU Xiu-feng8,SUN Jing9,DENG Hong10, GUAN Nian-hong11,LI Xiao-bai12,JIAO Zhi-an13,ZHANG Ke-rang14(1 Peking University Sixth Hospital,Beijing 100083,China;2 Beijing An Ding Hospital,Beijing 100088,China; 3 Beijing HuiLongGuan Hospital,Beijing 100096,China;4 Huashan Hospital Affiliated to Fudan University, Shanghai Mental Health Center,Shanghai 200030,China;5 Suzhou Guangji Hospital,Suzhou 215008,China; 6 Guangdong General Hospital,Guangdong Provincial Institute of Mental Health,Guangzhou 510120,China; 7 Shanghai Tongji Hospital Affiliated to Tongji University,Shanghai Mental Health Center,Shanghai 200030, China;8 First Affilliated Hospital of Kunming Medical College,Kunming 650032,China;9 Nanjing Brain Hospital,Nanjing 210029,China;10 West China Hospital of Sichuan,Chengdu 610041,China; 11 Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China;12 The First Hospital of China Medical University,Shenyang 110001,China;13 Shandong Provincial Hospital,Jinan 250021,China; 14 First Hospital of Shanxi Medical University,Taiyuan 030001,China)

【机构】 北京大学精神卫生研究所北京安定医院北京回龙观医院复旦大学附属华山医院上海市精神卫生中心苏州广济医院广东省人民医院广东省精神卫生研究所上海同济大学附属同济医院昆明医学院第一附属医院南京脑科医院四川华西医院中山大学第三附属医院中国医科大学第一附属医院山东省立医院山西医科大学第一医院

【摘要】 精神分裂症是一组病因未明的精神疾病,其病程迁延,易慢性化,多数患者会出现精神残疾。目前的治疗目标不仅是控制症状,还要改善患者的社会功能。文中综述了帕利哌酮缓释片的药理特点,并就其临床使用提出指导意见。帕利哌酮缓释片是一种新型第二代抗精神病药,其有效成分帕利哌酮是利培酮的活性代谢产物,同时OROS控释技术可以带来平稳的血药浓度。帕利哌酮缓释片起效迅速,能够全面有效控制症状,安全性良好,同时可以显著改善患者的社会功能。

【Abstract】 Schizophrenia is a group of disabling disorders with uncertain cause.Its course can be presented as one episode or span into a chronic state,ultimately requiring lifelong treatment.The treatment goals of schizophrenia are to rapidly control symptoms,and to gain a result of improved personal and social functioning.In this paper,clinical recommendation on paliperidone extended-release(ER) tablet in schizophrenia therapy was reviewed.Paliperidone ER is a recently developed atypical antipsychotic drug available for the treatment of schizophrenia.Paliperidone(9-hydroxy risperidone) is the major active metabolite of risperidone.By the unique extended-release delivery system,paliperidone ER can steadily deliver paliperidone and maintain steady plasma concentrations.It is efficacious in improving symptoms and social functioning of schizophrenia patients,and is well tolerated.

  • 【文献出处】 中国新药杂志 ,Chinese Journal of New Drugs , 编辑部邮箱 ,2011年16期
  • 【分类号】R971
  • 【被引频次】44
  • 【下载频次】833
节点文献中: 

本文链接的文献网络图示:

本文的引文网络